- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Syschem India Ltd — Board Meeting, 02-02-2026: Board Meeting
02-02-2026 | 03:28 pm
02-02-2026 | 03:28 pm
SYSCHEM (INDIA) LTD approved Q3 financial results: Revenue at ₹161.64 Cr, Profit at ₹4.17 Cr. Board also greenlit plant expansion for Amoxicillin, Ampicillin & CDF units, costing ₹14 Cr. Project to be commissioned by Dec 2026, boosting capacity.
No comments yet. Be the first to comment!